<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee180388b14">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <namePart>Health, Education, and Human Services Division</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">1996-03-08</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>50 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:HEHS-96-72</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-96-72</identifier>
<identifier type="local">P0b002ee180388b14</identifier>
<identifier type="former package identifier">f:he96072</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-28</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-HEHS-96-72</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-HEHS-96-72</accessId>
 <reportNumber>HEHS-96-72</reportNumber>
 <subject>Ethical conduct</subject>
 <subject>Biological research</subject>
 <subject>Behavioral sciences research</subject>
 <subject>Pharmacological research</subject>
 <subject>Safety regulation</subject>
 <subject>Research program management</subject>
 <subject>Safety standards</subject>
 <subject>Informed consent (medical law)</subject>
 <type>Letter Report</type>
 <seriesAbbrev>HEHS</seriesAbbrev>
</extension>
<titleInfo>
 <title>Scientific Research: Continued Vigilance Critical to Protecting Human Subjects</title>
</titleInfo>
<abstract>Pursuant to a congressional request, GAO reviewed the federal oversight
systems for protecting human subjects in federally sponsored scientific
experiments, focusing on whether the oversight procedures: (1) have
reduced the likelihood of abuses of human subjects; and (2) have
weaknesses that could limit their effectiveness.&lt;p/&gt;GAO found that: (1) federal efforts to prevent the abuse of human
research subjects include establishing institutional review boards,
educating the research community, and requiring written commitments from
researchers to comply with standards for the protection of human
subjects; (2) although these efforts work to prevent harm to
participants in most experimental studies, the effectiveness of those
standards in ensuring compliance has not been systematically studied;
(3) federal monitoring activities for the protection of human research
subjects include on-site inspections and reviews of study documentation,
institutional review board operations, and allegations of misconduct;
(4) actions to enforce the human research subject protection
requirements include research restrictions, researcher disqualification,
criminal prosecution, and suspensions from conducting further research;
and (5) the oversight procedures are impaired by institutional review
boards&apos; heavy workloads and competing demands, limited funds for on-site
inspections, the complexity and volume of research under review, and
reliance on researchers&apos; self-assurances that they are complying with
requirements.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-HEHS-96-72/html/GAOREPORTS-HEHS-96-72.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-HEHS-96-72/pdf/GAOREPORTS-HEHS-96-72.pdf</url>
</location>
<identifier type="preferred citation">GAO/HEHS-96-72</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-HEHS-96-72</url>
</location>
<note>Letter Report</note>
<extension>
 <searchTitle>GAO/HEHS-96-72; Scientific Research: Continued Vigilance Critical to Protecting Human Subjects;
            </searchTitle>
</extension>
<subject>
 <topic>Ethical conduct</topic>
 <topic>Biological research</topic>
 <topic>Behavioral sciences research</topic>
 <topic>Pharmacological research</topic>
 <topic>Safety regulation</topic>
 <topic>Research program management</topic>
 <topic>Safety standards</topic>
 <topic>Informed consent (medical law)</topic>
</subject>
</mods>